CVE-2017-14111The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an…
Updated under an hour ago ()
Does this affect you?
It affects philips intellispace_cardiovascular and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 2.17%, higher than 82% of scored CVEs.
Do this next
Free account, 1 product
The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an attacker to use credentials to access the application, or other user entitlements.
- CVSS
- 7.2 HIGH (v3.0, NVD)CVSS:3.0/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 2.17% (percentile 82)
- Assigned by
- mitre
- NVD analysis
- Modified
- Record last updated
- Aug 5, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
philips intellispace_cardiovascular philips:intellispace_cardiovascular | through 2.3.0 | NVD |
philips xcelera philips:xcelera | through r4.1l1 | NVD |
References
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityx-refsource-confirm, issue-tracking, mitigation, vendor-advisory
- http://www.securityfocus.com/bid/101850vdb-entry, x-refsource-bid, third-party-advisory
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01x-refsource-misc, issue-tracking, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.